Abstract
Parkinson’s disease is characterized by the selective degeneration of neuromelanin-containing dopaminergic neurons in the substantia nigra and locus coeruleus. Although the cause of this disease remains unknown, several transition metals, including manganese and copper, have been associated with the development of the atypical form of Parkinsonism, and iron accumulation has been associated with the development of Parkinson’s disease. Manganese3+ is a strong oxidizing agent, which oxidizes dopamine to aminochrome (dopaminochrome), the precursor of neuromelanin. Aminochrome formation in cell culture medium induces acute cell death in cells that uptake aminochrome, explaining the role of manganese in the development of atypical Parkinsonism. Copper accumulation in Wilson’s disease also induces Parkinsonism as one of the main symptoms, and an atypical Parkinsonism has also been observed in young copper miners. Interestingly, copper is able to complex with dopamine, which can be taken up by cells expressing the dopamine transporter, inducing caspase-independent cell death with formation of autophagic vacuoles. Iron is also able to form a complex with dopamine, the neurotoxic action of which also depends on the cellular expression of the dopamine transporter. The neurotoxicities of these transition metals to cells expressing the dopamine transporter all involve dopamine oxidation to quinones and require the inhibition of DT-diaphorase.
Graphical Abstract
Similar content being viewed by others
References
HaMai D, Bondy SC (2004) Ann N Y Acad Sci 1012:129
Sriram K, Lin GX, Jefferson AM, Roberts JR, Chapman RS, Chen BT, Soukup JM, Ghio AJ, Antonini JM (2010) Arch Toxicol 84:521
Settivari R, Levora J, Nass R (2009) J Biol Chem 284:35758
Zhang P, Lokuta KM, Turner DE, Liu B (2010) J Neurochem 112:434
Zhang P, Wong TA, Lokuta KM, Turner DE, Vujisic K, Liu B (2009) Exp Neurol 217:219
Moreno JA, Streifel KM, Sullivan KA, Legare ME, Tjalkens RB (2009) Toxicol Sci 112:405
Zhao F, Cai T, Liu M, Zheng G, Luo W, Chen J (2009) Toxicol Sci 107:156
Posser T, Franco JL, Bobrovskaya L, Leal RB, Dickson PW, Dunkley PR (2009) J Neurochem 110:848
Stanwood GD, Leitch DB, Savchenko V, Wu J, Fitsanakis VA, Anderson DJ, Stankowski JN, Aschner M, McLaughlin B (2009) J Neurochem 110:378
Prabhakaran K, Ghosh D, Chapman GD, Gunasekar PG (2008) Brain Res Bull 76:361
Anderson JG, Cooney PT, Erikson KM (2007) Environ Toxicol Pharmacol 3:179
McDougall SA, Reichel CM, Farley CM, Flesher MM, Der-Ghazarian T, Cortez AM, Wacan JJ, Martinez CE, Varela FA, Butt AE, Crawford CA (2008) Neuroscience 154:848
Hirata Y, Suzuno H, Tsuruta T, Oh-hashi K, Kiuchi K (2008) Toxicology 244:249
Williams BB, Kwakye GF, Wegrzynowicz M, Li D, Aschner M, Erikson KM, Bowman AB (2010) Toxicol Sci 117:169
Hirsch EC (2009) Parkinsonism Relat Disord 15:S209
Du T, Ciccotosto GD, Cranston GA, Kocak G, Masters CL, Crouch PJ, Cappai R, White AR (2008) Free Radic Biol Med 44:44
Zhang S, Wang J, Song N, Xie J, Jiang H (2009) Neurobiol Aging 30:1466
Huang E, Ong WY, Go ML, Connor JR (2006) Exp Brain Res 170:376
Huang E, Ong WY, Connor JR (2004) Neuroscience 128:487
Aguirre P, Mena N, Tapia V, Arredondo M, Núñez MT (2005) BMC Neurosci 6:3
Lis A, Barone TA, Paradkar PN, Plunkett RJ, Roth JA (2004) Brain Res Mol Brain Res 122:62
Knutson M, Menzies S, Connor J (2004) J Neurosci Res 76:633
Wang XS, Ong WY, Connor JR (2003) 120:21
Burdo JR, Menzies SL, Simpson IA, Garrick LM, Garrick MD, Dolan KG, Haile DJ (2001) J Neurosci Res 66:1198
Perl DP, Olanow CW (2007) J Neuropathol Exp Neurol 66:675
Donaldson J, LaBella FS, Gesser D (1981) Neurotoxicology 2:53
Archibald FS, Tyree C (1987) Arch Biochem Biophys 256:638
Segura-Aguilar J, Lind C (1989) Chem Biol Interact 72:309
Stredrick DL, Stokes AH, Worst TJ, Freeman WM, Johnson EA, Lash LH
Eriksson H, Heilbronn E (1983) Arch Toxicol 54:53
Cai T, Yao T, Li Y, Chen Y, Du K, Chen J, Luo W (2007) Brain Res 1185:359
Arriagada C, Paris I, Sanchez de las Matas MJ, Martinez-Alvarado P, Cardenas S, Castañeda P, Graumann R, Perez-Pastene C, Olea-Azar C, Couve E, Herrero MT, Caviedes P, Segura-Aguilar J (2004) Neurobiol Dis 16:468
Segura-Aguilar J, Metodiewa D, Baez S (2001) Neurotox Res 3:157
Paris I, Dagnino-Subiabre A, Marcelain K, Bennett LB, Caviedes P, Caviedes R, Azar CO, Segura-Aguilar J (2001) J Neurochem 77:519
Paris I, Martinez-Alvarado P, Perez-Pastene C, Vieira MN, Olea-Azar C, Raisman-Vozari R, Cardenas S, Graumann R, Caviedes P, Segura-Aguilar J (2005) J Neurochem 92:1021
Paris I, Cardenas S, Lozano J, Perez-Pastene C, Graumann R, Riveros A, Caviedes P, Segura-Aguilar J (2007) Neurotox Res 12:125
Paris I, Lozano J, Perez-Pastene C, Muñoz P, Segura-Aguilar J (2009) Neurotox Res 16:271
Paris I, Perez-Pastene C, Cardenas S, Iturriaga-Vasquez P, Muñoz P, Couve E, Caviedes P, Segura-Aguilar J (2010) Neurotox Res 18:82
Paris I, Perez-Pastene C, Couve E, Caviedes P, Ledoux S, Segura-Aguilar J (2009) J Biol Chem 284:13306
Fuentes P, Paris I, Nassif M, Caviedes P, Segura-Aguilar J (2007) Chem Res Toxicol 20:776
Segura-Aguilar J, Diaz-Veliz G, Mora S, Herrera-Marschitz M (2002) Neurotox Res 4:127
Paris I, Lozano J, Cardenas S, Perez-Pastene C, Saud K, Fuentes P, Caviedes P, Dagnino-Subiabre A, Raisman-Vozari R, Shimahara T, Kostrzewa JP, Chi D, Kostrzewa RM, Caviedes R, Segura-Aguilar J (2008) Neurotox Res 13:221
Díaz-Véliz G, Mora S, Gómez P, Dossi MT, Montiel J, Arriagada C, Aboitiz F, Segura-Aguilar J (2004) Pharmacol Biochem Behav 77:245
Díaz-Véliz G, Mora S, Dossi MT, Gómez P, Arriagada C, Montiel J, Aboitiz F, Segura-Aguilar J (2002) Pharmacol Biochem Behav 73:843
Strausak D, Mercer JF, Dieter HH, Stremmel W, Multhaup G (2001) Brain Res Bull 55:175
Du F, Qian ZM, Zhu L, Wu XM, Yung WH, Tsim TY, Ke Y (2009) PLoS One 4:e4593
White AR, Cappai R (2003) J Neurosci Res 71:889
Reddy PV, Rao KV, Norenberg MD (2008) Lab Invest 88:816
Lu J, Zheng YL, Wu DM, Sun DX, Shan Q, Fan SH (2006) FEBS Lett 580:6730
Lu J, Wu DM, Zheng YL, Sun DX, Hu B, Shan Q, Zhang ZF, Fan SH (2009) Brain Behav Immun 23:193
Zheng Z, White C, Lee J, Peterson TS, Bush AI, Sun GY, Weisman GA, Petris MJ (2010) J Neurochem 114:1630
Taly AB, Meenakshi-Sundaram S, Sinha S, Swamy HS, Arunodaya GR (2007) Medicine (Baltimore) 86:112
Caviedes P, Segura-Aguilar J (2001) Neuroreport 12:A25
Segura-Aguilar J, Metodiewa D, Welch CJ (1998) Biochim Biophys Acta 1381:1
Díaz-Véliz G, Paris I, Mora S, Raisman-Vozari R, Segura-Aguilar J (2008) Chem Res Toxicol 21:1180
Wimalasena DS, Wiese TJ, Wimalasena K (2009) J Neurochem 101:313
Kume A, Shiratori M, Takahashi A, Kato T, Ito K, Tadokoro M, Sakuma S (1992) J Neurol Sci 110:37
Zhang J, Zhang Y, Wang J, Cai P, Luo C, Qian Z, Dai Y, Feng H (2010) Brain Res 1330:124
Song N, Jiang H, Wang J, Xie JX (2007) J Neurosci Res 85:3118
Roth JA, Singleton S, Feng J, Garrick M, Paradkar PN (2010) J Neurochem 113:454
Hirsch EC (2009) Parkinsonism Relat Disord 15:S209
Salazar J, Mena N, Hunot S, Prigent A, Alvarez-Fischer D, Arredondo M, Duyckaerts C, Sazdovitch V, Zhao L, Garrick LM, Nuñez MT, Garrick MD, Raisman-Vozari R, Hirsch EC (2008) Proc Natl Acad Sci USA 105:18578
Wang J, Jiang H, Xie JX (2007) Eur J Neurosci 25:2766
Song N, Wang J, Jiang H, Xie J (2010) Free Radic Biol Med 48:332
Zhu W, Li X, Xie W, Luo F, Kaur D, Andersen JK, Jankovic J, Le W (2010) Neurobiol Dis 37:307
Kaur D, Lee D, Ragapolan S, Andersen JK (2009) Free Radic Biol Med 46:593
Tribl F, Asan E, Arzberger T, Tatschner T, Langenfeld E, Meyer HE, Bringmann G, Riederer P, Gerlach M, Marcus K (2009) Mol Cell Proteomics 8:1832
Youdim MB, Grünblatt E, Mandel S (2007) J Neural Transm 114:205
Xu Q, Kanthasamy AG, Reddy MB (2008) Toxicology 245:101
Maharaj DS, Maharaj H, Daya S, Glass BD (2006) J Neurochem 96:78
Wang R, Qing H, Liu XQ, Zheng XL, Deng YL (2008) Neurosci Bull 24:125
Zecca L, Casella L, Albertini A, Bellei C, Zucca FA, Engelen M, Zadlo A, Szewczyk G, Zareba M, Sarna T (2008) J Neurochem 106:1866
Double KL, Halliday GM, Henderson J, Griffiths FM, Heinemann T, Riederer P, Gerlach M (2003) Exp Neurol 184:530
Paris I, Martinez-Alvarado P, Cárdenas S, Perez-Pastene C, Graumann R, Fuentes P, Olea-Azar C, Caviedes P, Segura-Aguilar J (2005) Chem Res Toxicol 18:415
Arreguin S, Nelson P, Padway S, Shirazi M, Pierpont C (2009) J Inorg Biochem 103:87
Siraki AG, Smythies J, O’Brien PJ (2000) Neurosci Lett 296:37
Ortega R, Cloetens P, Devès G, Carmona A, Bohic S (2007) PLoS One 2:e925
Mohamed GG, Zayed MA, El-Dien FA, El-Nahas RG (2004) Spectrochim Acta A 60:1775
Arriagada C, Dagnino-Subiabre A, Caviedes P, Armero JM, Caviedes R, Segura-Aguilar J (2000) Amino Acids 18:363
Acknowledgments
Supported by FONDECYT 1100165.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Paris, I., Segura-Aguilar, J. The role of metal ions in dopaminergic neuron degeneration in Parkinsonism and Parkinson’s disease. Monatsh Chem 142, 365–374 (2011). https://doi.org/10.1007/s00706-011-0478-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-011-0478-6